Relapsed Acute Lymphoblastic Leukemia (ALL) Completed Phase 2 / 3 Trials for Asparaginase Escherichia coli (DB00023)

Back to Relapsed Acute Lymphoblastic Leukemia (ALL)

Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia

Indication	Status	Phase
DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL))	Completed	2 / 3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01518517	GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia	Treatment	Asparaginase Escherichia coli (DB00023) Red blood cell-encapsulated L-asparaginase (DB17477)